Suppr超能文献

[波兰妇科协会专家组关于使用Macmiror Complex 500的声明]

[Statement of the Polish Gynecological Society Expert Group on the use of Macmiror Complex 500].

出版信息

Ginekol Pol. 2012 Dec;83(12):956-9.

Abstract

The group of experts representing the Polish Gynecologic Society has issued this statement based on the review of available literature on the potential benefits of the use of Macmiror Complex 500 in obstetrical and gynecologic practice. Mixed Vaginitis (MV) eg. the vaginal infection caused by at least two out of the triad of pathogens (fungi, bacteria and Trichomonas Vaginalis [TV]), constitutes the type of vaginitis which is underestimated as for its prevalence. Mixed pathogens are responsible for as much as one third of all vaginal infections. Macmiror Complex 500 contains two active ingredients: nifuratel and nystatin. Macmiror Complex 500 affects all common causes of vulvovaginitis, i.e. bacteria, yeasts and TV. At the same time, it is not effective against Lactobacillus spp., which is a clear advantage in the treatment of vaginal infections. The antibacterial spectrum of nifuratel includes aerobic and anaerobic bacteria. Moreover nifuratel is effective against Chlamydia trachomatis and Mycoplasma spp., it has an anti-trichomonal effect comparable to metranidazole and shows certain activity against Candida spp. Nystatin is effective against Candida albicans and is even very effective against Candida glabrata which is usually more resistant to imidazole antifungal agents. Nystatin's importance is rising due to the current increase of candidoses caused by non-albicans types. This increase is especially perceptible in recurring candidoses. The review of the available literature on the effectiveness of Macmiror Complex 500 in the OB/GYN practice leads to the following conclusions: the exeptionally broad antibacterial and antifungal and trichomonicidal activity of this formulation makes it a drug of choice in cases where MV is suspected. The possibility to treat both partners, favorable safety profile in pregnant patients and the availability of both vaginal ovules and the cream with applicator makes this drug an effective and suitable treatment option in obstetrical and gynecologic practice.

摘要

代表波兰妇科协会的专家小组,在回顾了关于在妇产科实践中使用麦米诺复合制剂500潜在益处的现有文献后,发表了本声明。混合性阴道炎(MV),例如由病原体三联体(真菌、细菌和阴道毛滴虫[TV])中至少两种引起的阴道感染,是一种在患病率方面被低估的阴道炎类型。混合病原体导致了高达三分之一的所有阴道感染。麦米诺复合制剂500含有两种活性成分:硝呋太尔和制霉菌素。麦米诺复合制剂500对所有常见的外阴阴道炎病因均有作用,即细菌、酵母菌和TV。同时,它对乳酸杆菌属无效,这在治疗阴道感染方面是一个明显的优势。硝呋太尔的抗菌谱包括需氧菌和厌氧菌。此外,硝呋太尔对沙眼衣原体和支原体属有效,其抗滴虫作用与甲硝唑相当,并且对念珠菌属有一定活性。制霉菌素对白色念珠菌有效,甚至对通常对咪唑类抗真菌药更具耐药性的光滑念珠菌也非常有效。由于目前非白色念珠菌类型引起的念珠菌病增加,制霉菌素的重要性日益凸显。这种增加在复发性念珠菌病中尤为明显。对现有文献中麦米诺复合制剂500在妇产科实践中有效性的回顾得出以下结论:该制剂具有异常广泛的抗菌、抗真菌和杀滴虫活性,使其成为怀疑有MV时的首选药物。能够同时治疗双方伴侣、在孕妇中具有良好的安全性以及有阴道栓剂和带 applicator 的乳膏可供使用,使得这种药物在妇产科实践中成为一种有效且合适的治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验